而药物外渗是临床静脉输注化疗药物的严重并发症之一。
And clinical drug extravasation of chemotherapeutic drugs by intravenous infusion of one of serious complications.
目的探讨急诊输液区输注化疗药物的管理及药物渗漏的应急处理方法。
Objective This paper discusses the emergency infusion of chemotherapy infusion areas of management and drug leakage in the emergency treatment.
方法：全组51例均采用静脉腹腔联合化疗，并从配药、穿刺、引流腹水、输注化疗药物整个化疗过程，实施一系列的护理措施。
Methods: the combined venous and celiac chemotherapy was applied to all 51 patients and series nursing was adopted in the whole courses of dispensing, puncture, drainage of ascetic fluid and infusion.
在临床输注领域的领先技术充分保障了化疗泵持续微量给药的准确性和可靠性。
Infusion in the clinical technology leader in the field of providing adequate protection for chemotherapy drug delivery pump continued to trace the accuracy and reliability.
化疗结束后，把这些储存的造血干细胞回注进患者血液中。
The stored stem cells are infused back into the patient's blood after treatment with chemotherapy ends.
方法：总结92例急性白血病患者在接受诱导缓解化疗、巩固化疗及强化治疗期间的出血表现、血小板计数变化及输注血小板情况。
Methods: Hemorrhagic tendencies, peripheral blood platelet counts and volumes of platelet infusion during different phase of chemotherapy in 92 patients were summarized.
目的探讨不同静脉输注方式对化疗性静脉损伤程度的影响。
Objective To study the damage severity of peripheral vein by taking different intravenous infusion methods.
笔者对导管的选择，化疗药物的联合应用，药物剂量，浓度，推注时间，以及对该法的合理性、操作注意事项等进行了探讨。
Selection of catheter, combination application of the chemotherapeutants, infusion dose, concentration, duration of the infusion and feasibility of the procedure were discussed.
目的：开发脐血血浆的临床应用价值，探讨脐血血浆输注对急性白血病患者化疗后血象恢复的影响。
Objective: To discuss the influence of the blood in patients with acute leukemia after infusing cord blood plasma.
用妊娠4 ~5月胎肝制成新鲜胎肝细胞悬液输注，治疗了再障和化疗后的白血病。
Freshly prepared fetal liver cell suspension derived from the foetuses of 4-5 months of gestation were transfused to a group of patients with aplastic anaemia and leukemia after chemotherapy.
结果：接受诱导缓解化疗的急性白血病患者，出血倾向轻重不一，输注血小板的比例为31.5%；
Results : The patients subjected to remission-induction chemotherapy had mild to severe bleeding trends , the platelet transfusion rate was 31.5% ;
主要不良反应为输注相关的不良反应（32 % ）和化疗相关的血液学毒副反应（2 0 % ）。
The regimen could be well tolerated, and the major adverse reactions were infusion-related response (32%) and hematological toxicities (20%).
尽量选用中心静脉置管等措施以减少便携式化疗泵持续输注氟尿嘧啶时间差。
Meanwhile, measures such as central vein catheter would reduce the time difference as well.
尽量选用中心静脉置管等措施以减少便携式化疗泵持续输注氟尿嘧啶时间差。
Meanwhile, measures such as central vein catheter would reduce the time difference as well.
应用推荐